{"id":"W2913106255","doi":"10.1016/j.jaci.2018.11.053","title":"GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis","year":2019,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":222,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada)","funders":"Glenmark Pharmaceuticals","keywords":"Eczema Area and Severity Index; Atopic dermatitis; Medicine; Placebo; CCL11; Adverse effect; CCL17; Internal medicine; Body surface area; Gastroenterology; Skin biopsy; Biopsy; Immunology; CXCL10; Chemokine; Inflammation; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003816376,0.0001611412,0.0008420503,0.0001226959,0.0000441432,0.0000158473,0.0001333238,0.0004480221,0.00008992519],"category_scores_gemma":[0.0002975972,0.0001095363,0.0001338887,0.00006269348,0.0005326678,0.0002117745,0.00007232679,0.0008270966,0.000006270791],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008923014,"about_ca_system_score_gemma":0.000128523,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001047249,"about_ca_topic_score_gemma":0.00004145292,"domain_scores_codex":[0.9979457,0.0003557088,0.001083861,0.0002474068,0.0001387509,0.0002286343],"domain_scores_gemma":[0.9985425,0.0004613863,0.0004333211,0.0002174766,0.0001630473,0.0001822938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001361219,0.001170594,0.9848316,0.00001902068,0.001030707,0.0001967294,0.00004344119,0.000001404762,0.00002523105,0.00007042196,0.000332181,0.01091745],"study_design_scores_gemma":[0.009831945,0.003668365,0.9844501,0.0001312968,0.0001254213,0.0002346282,0.00006982969,0.00003252428,0.00003169743,0.0002598745,0.0010431,0.0001212345],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942816,0.004200407,0.000008670586,0.000686475,0.0005695435,0.0001530675,0.000002501964,0.000007851821,0.00008983464],"genre_scores_gemma":[0.9929721,0.00513445,0.0003288173,0.001368583,0.0001130118,9.52396e-7,0.000009972033,0.00001272072,0.00005943438],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01079622,"threshold_uncertainty_score":0.4466762,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01003439173240979,"score_gpt":0.2991725719075664,"score_spread":0.2891381801751566,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}